Drug intelligence / Profile preview

acitretin + prednicarbate

Development stage
Unknown
Lead developer
Roche
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Acitretin + prednicarbate is a combination of two dermatological agents used for the treatment of skin disorders, particularly those involving inflammation, hyperproliferation, and keratinization such as psoriasis. Acitretin is an oral retinoid that modulates epidermal cell proliferation and differentiation by binding to nuclear retinoic acid receptors, leading to anti-inflammatory and antiproliferative effects. Prednicarbate is a medium-potency topical corticosteroid that reduces inflammation, itching, and redness by inhibiting multiple inflammatory cytokines through glucocorticoid receptor activation. The combination aims to leverage the systemic effects of acitretin with the local anti-inflammatory action of prednicarbate for enhanced efficacy in managing moderate-to-severe skin conditions[1][4][8].

02

Targets

GR (Glucocorticoid receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on acitretin + prednicarbate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acitretin + prednicarbate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call